Slaughter and May has advised INEOS Enterprises. Ropes & Gray has advised Ecovyst Inc. INEOS Enterprises has entered into an agreement to sell its Calabrian sulfur...
INEOS Enterprises Sells Calabrian Sulfur Business to Ecovyst for $190 Million
Sanofi and EQT Life Sciences Invest in SpliceBio’s $135 Million Series B Financing
Ropes & Gray has advised Sanofi and EQT Life Sciences on the transaction. Sanofi and EQT Life Sciences have participated in a $135 million Series B...
Draig Therapeutics Secures $140 Million in Total Financing Since Inception
Covington & Burling and Taylor Wessing advised Draig Therapeutics Limited on the transaction, and Ropes & Gray has advised Sanofi. Draig Therapeutics Limited has secured a...
Pfizer’s $25 Million Strategic Investment in CellCentric
Ropes & Gray advised Pfizer on the deal. Pfizer announced its strategic investment in and collaboration with CellCentric, which includes $25 million to help finance further development...
Redx Pharma’s Merger with Jounce Therapeutics
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
In re Pandora Media LLC Copyright Litigation
Cravath represented Word Collections in the case. On October 26, 2022, the U.S. District Court for the Central District of California granted Cravath’s motion to dismiss...
NeoGenomics’ Acquisition of Inivata
Ropes & Gray advised NeoGenomics on the deal. NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, executed its...
Boston Scientific’s $1.07 Billion Acquisition of Lumenis Surgical Business
Ropes & Gray represented an affiliate of Baring Private Equity Asia in the transaction, while Yigal Arnon & Co. and Latham & Watkins represented Boston Scientific,...